LURASIDONE HYDROCHLORIDE
| Brand name | LATUDA |
|---|---|
| Active ingredient | LURASIDONE HYDROCHLORIDE |
| Strength | 60MG |
| Dosage form | TABLET |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | July 2013 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 9259423*PED | November 2031 | — |
| 9259423 | May 2031 | use U-1822 |
| 9827242 | May 2031 | use U-2201 |
| 8883794*PED | November 2026 | — |
| 8729085*PED | November 2026 | — |
| 9907794*PED | November 2026 | — |
| 8883794 | May 2026 | product |
| 9555027 | May 2026 | product |
| 8729085 | May 2026 | product |
| 9907794 | May 2026 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.